They found that, regardless of HCC etiology, the plasma levels of Ang-2, associated with other prognostic factors such as tumor stage, invasiveness and liver function, were better prognostic marker of OS and PFS compared to AFP, VEGF and Ang-1. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.